Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shanyuan Zheng"'
Autor:
Peigang Liang, Jiaqi Zhang, Yuchen Wu, Shanyuan Zheng, Zhaopeng Xu, Shuo Yang, Jinfang Wang, Suibin Ma, Li Xiao, Tianhui Hu, Wenxue Jiang, Qiong Xing, Mondira Kundu, Bo Wang
The remodeling and stiffening of the extracellular matrix (ECM) associated with breast cancers is a well-recognized modulator of disease progression. However, how changes in the mechanical properties of the ECM are converted into biochemical signals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85d04b7f1a936e66e659badb09a263d2
https://doi.org/10.1101/2023.02.03.526950
https://doi.org/10.1101/2023.02.03.526950
Autor:
Peigang Liang, Yuchen Wu, Shanyuan Zheng, Jiaqi Zhang, Shuo Yang, Jinfang Wang, Suibin Ma, Mengjun Zhang, Zhuang Gu, Qingfeng Liu, Wenxue Jiang, Qiong Xing, Bo Wang
Focal adhesions (FAs) are transmembrane protein assemblies mediating cell-matrix connection. Tools to manipulate the compositionally intricate and dynamic FAs are currently limited, rendering many fundamental hypotheses untestable. Although protein l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b93b444d10cdc9d954aeb791f8c846ff
https://doi.org/10.1101/2022.12.17.520852
https://doi.org/10.1101/2022.12.17.520852
Autor:
Yum Shing Wong, Shanyuan Zheng, Keith Kwong Hon Wong, Tianfeng Chen, Jun Sheng Zheng, Sai-Ming Ngai, Yibo Zhang, Zhi Huang, Wenjie Zheng
Publikováno v:
Molecular Pharmaceutics. 11:1282-1293
Cisplatin-based therapy is one of the most important chemotherapy treatments for cancers. However, its efficacy is greatly limited by drug resistance and undesirable side effects. Therefore, it is of great importance to develop chemosensitizing agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c967a7b35aae9f242b5fb9ff2286d90
https://doi.org/10.1021/mp400749f
https://doi.org/10.1021/mp400749f
Autor:
Wenjie Zheng, Hao Liu, Xie Xinyuan, Yangqiu Li, Zeping Weng, Yikai Zhang, Jun Ma, Shanyuan Zheng
Publikováno v:
Biochemical and biophysical research communications. 477(4)
Selective induction of cell death or growth inhibition of cancer cells is the future of chemotherapy. Clinical trials have found that cancer tissues are enriched with copper. Based on this finding, many copper-containing compounds and complexes have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1041174f41aa57c1c8fb5745552f2afb
https://pubmed.ncbi.nlm.nih.gov/27392714
https://pubmed.ncbi.nlm.nih.gov/27392714
Autor:
Peigang Liang1 bowang@xmu.edu.cn, Yuchen Wu1, Shanyuan Zheng1, Jiaqi Zhang1, Shuo Yang1, Jinfang Wang1, Suibin Ma1, Mengjun Zhang1, Zhuang Gu1, Qingfeng Liu1, Wenxue Jiang2, Qiong Xing2, Bo Wang1,3
Publikováno v:
Journal of Cell Biology. 4/1/2024, Vol. 223 Issue 4, p1-17. 23p.
Publikováno v:
Oncotarget
Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL), as one of the most promising targeted drug for new cancer therapeutics, is limited in clinical application by the evolution of resistance in many cancer cell lines, especially in mali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a41d0cd087e77dec079c922c9c28e505
https://pubmed.ncbi.nlm.nih.gov/25277183
https://pubmed.ncbi.nlm.nih.gov/25277183
A novel selenadiazole derivative induces apoptosis in human glioma cells by dephosphorylation of AKT
Autor:
Sai-Ming Ngai, Yikai Zhang, Wenjie Zheng, Shanyuan Zheng, Jin-ying Li, Tianfeng Chen, Xueyun Zhong
Publikováno v:
Chemicalpharmaceutical bulletin. 62(10)
Selenadiazole derivatives are synthetic organoselenium compounds with improved anticancer activity and greater selectivity than inorganic selenium. In this study, 4-(benzo[c][1,2,5]selenadiazol-6-yl)-benzene-1,2-diamine (BSBD) was shown to induce tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d234aeac7e47f0d21c578d0444ff53c
https://pubmed.ncbi.nlm.nih.gov/25273058
https://pubmed.ncbi.nlm.nih.gov/25273058
Autor:
Shanyuan Zheng, Xiaoling Li, Yibo Zhang, Qiang Xie, Yum-Shing Wong, Wenjie Zheng, Tianfeng Chen
Publikováno v:
International Journal of Nanomedicine; 2012, Vol. 7, p3939-3949, 11p